Bustamante, Jennylyn .
HRN: 13-15-87 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2024
CEFUROXIME 500MG (TAB)
01/10/2024
01/17/2024
ORAL
500mg
BID
Urinary Tract Infection
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes